内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Sawaf Aziz. Officer active across 1 company, notably Theravance Biopharma, Inc.. Cumulatively, 18 reports have been logged. History available since 20 February 2023. The latest transaction was disclosed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sawaf Aziz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
8,112 股@ US$16.950.016% mcap6.9% 占其流量Ordinary SharesSEC:0001961289-26-000008:0
37,500 股0Ordinary SharesSEC:0001961289-26-000004:0
20,672 股@ US$19.6621.8% 占其流量Ordinary SharesSEC:0001961289-26-000002:0
18,627 股@ US$17.9023.3% 占其流量Ordinary SharesSEC:0001961289-25-000006:0
9,368 股@ US$13.3911.3% 占其流量Ordinary SharesSEC:0001415889-25-022801:0
9,348 股@ US$9.459.3% 占其流量Ordinary SharesSEC:0001415889-25-014261:0
75,000 股0Ordinary SharesSEC:0001415889-25-006679:0
13,751 股@ US$9.6615.1% 占其流量Ordinary SharesSEC:0001415889-25-005353:0
8,477 股@ US$9.979.5% 占其流量Ordinary SharesSEC:0001415889-24-027571:0
8,635 股@ US$8.227.6% 占其流量Ordinary SharesSEC:0001415889-24-022090:0
8,635 股@ US$9.108.6% 占其流量Ordinary SharesSEC:0001415889-24-014139:0
100,000 股0Ordinary SharesSEC:0001415889-24-010326:0
17,036 股@ US$8.9216.7% 占其流量Ordinary SharesSEC:0001415889-24-004966:0
6,187 股@ US$10.377.0% 占其流量Ordinary SharesSEC:0001415889-23-015452:0
7,114 股@ US$9.707.5% 占其流量Ordinary SharesSEC:0001415889-23-012520:0
8,744 股@ US$11.2110.8% 占其流量Ordinary SharesSEC:0001415889-23-008674:0
80,000 股0Ordinary SharesSEC:0001415889-23-004275:0
6,783 股@ US$10.447.9% 占其流量Ordinary SharesSEC:0001415889-23-003075:0
About Sawaf Aziz
Sawaf Aziz is a declarant linked to Theravance Biopharma, Inc., where the listed role is SVP & CHIEF FINANCIAL OFFICER. The record covers 17 filings, with recent filings observed from 2023-02-22 to 2026-04-03, and the most frequent transaction nature is Tax withholding.